TWISTER OXYGEN CONCENTRATOR MODEL 600, TWISTER OXYGEN CONCENTRATOR W/OPI MODEL 605

K972614 · Healthdyne Technologies, Inc. · CAW · Jan 20, 1998 · Anesthesiology

Device Facts

• Record ID: K972614
• Device Name: TWISTER OXYGEN CONCENTRATOR MODEL 600, TWISTER OXYGEN CONCENTRATOR W/OPI MODEL 605
• Applicant: Healthdyne Technologies, Inc.
• Product Code: CAW · Anesthesiology
• Decision Date: Jan 20, 1998
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 868.5440
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Twister Oxygen Concentrator is intended to provide supplemental oxygen to persons requiring low flow oxygen therapy. This device is not intended to be life supporting nor life sustaining.

Device Story

Twister Oxygen Concentrator extracts oxygen from room air; utilizes molecular sieve and pressure swing adsorption (PSA) process; delivers concentrated oxygen to patients requiring low flow therapy. Device intended for non-life-supporting/non-life-sustaining use. Operated in clinical or home settings to provide supplemental oxygen; healthcare provider or patient manages delivery based on clinical need.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Oxygen concentrator utilizing molecular sieve and pressure swing adsorption (PSA) technology to concentrate oxygen from ambient room air. Form factor designed for low flow oxygen delivery.

Indications for Use

Indicated for persons requiring low flow oxygen therapy. Not for life-supporting or life-sustaining use.

Regulatory Classification

Identification

A portable oxygen generator is a device that is intended to release oxygen for respiratory therapy by means of either a chemical reaction or physical means (e.g., a molecular sieve).

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized image of an eagle with its wings spread, and its head turned to the right. The eagle is surrounded by a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" written around it.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JAN 20 1998

Ms. Betsy Cortelloni Healthdyne Technologies 1255 Kennestone Circle Marietta, GA 30066

K972614 Re : Twister Oxygen Concentrator Regulatory Class: II (two) 73 CAW Product Code: December 11, 1997 Dated: December 12, 1997 Received:

Dear Ms. Cortelloni:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such Existing major regulations affecting your device additional controls. can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21_CFR Part 820) and that, through periodic_(QS) --------inspections, the Food and Drug Administration (FDA) will verify such Failure to comply with the GMP regulation may result in assumptions. requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

{1}------------------------------------------------

## Page 2 - Ms. Betsy Cortelloni

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone] or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

Thomas J. Callahan

Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

510(k) Number (if known):

Device Name: TWISTER OXYGEN CONCENTRATOR

Indications For Use:

体

The Twister Oxygen Concentrator is intended to provide The Twitter a loxygen to persons requiring low flow oxygen therapy. This device is not intended to be life supporting nor life sustaining.

The Twister produces concentrated oxygen from room air for delivery to a patient requiring low flow oxygen therapy. The oxygen from the air is concentrated using a molecular sieve and a pressure swing adsorption process.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Ma. Pagli-

(Division Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devices

< 972614 510(k) Number __

Prescription Use U (Per 21 CFR 801.109)

CR

Over-The-Counter Use_.._______________________________________________________________________________________________________________________________________________________

(Optional Format 1-2-96)

い